The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival

Protein Cell. 2017 Nov;8(11):856-860. doi: 10.1007/s13238-017-0441-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • B-Cell CLL-Lymphoma 10 Protein / deficiency
  • B-Cell CLL-Lymphoma 10 Protein / metabolism*
  • CARD Signaling Adaptor Proteins / deficiency
  • CARD Signaling Adaptor Proteins / metabolism*
  • Cell Survival / drug effects
  • DNA Damage*
  • Doxorubicin / pharmacology
  • HeLa Cells
  • Humans
  • Mice
  • Mice, Knockout
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein / deficiency
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein / metabolism*
  • NF-kappa B / metabolism*

Substances

  • Antineoplastic Agents
  • B-Cell CLL-Lymphoma 10 Protein
  • BCL10 protein, human
  • CARD Signaling Adaptor Proteins
  • CARD10 protein, human
  • NF-kappa B
  • Doxorubicin
  • MALT1 protein, human
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein